How might you approach B2G SaaS pricing?

Start with the reality of B2G in medtech: procurement drives pricing

B2G (business-to-government) SaaS pricing is constrained less by what your product is “worth” and more by how the government can buy it. In medtech, that constraint is amplified by security requirements, clinical risk, and integration work (EHR, imaging, device data). Your pricing has to survive: (1) budget cycles, (2) procurement rules, (3) security reviews, and (4) long sales timelines.

Two practical implications:

• Expect fewer, larger contracts than B2B SMB SaaS. You’ll likely price as an annual contract with defined scope, not month-to-month.
• Separate “software value” from “government friction costs.” Implementation, security documentation, and integrations are real costs; if you bury them in a low subscription price, you’ll underprice and stall delivery.

Medtech note: if your SaaS touches clinical decision-making, patient monitoring, or diagnostic workflows, your buyer may ask about FDA pathway (510(k), De Novo, PMA) even if you believe you’re “just software.” That uncertainty affects pricing because it affects risk and timeline. If you’re pre-clearance, price pilots and limited deployments accordingly.

Pick a value metric that matches government budgets (not startup instincts)

A value metric is the unit you charge on (per user, per facility, per patient, per device, per study, etc.). In B2G, the best value metric is one that is:

• Easy to forecast for the agency (fits their budget planning).
• Hard to game (doesn’t incentivize reducing usage of a beneficial tool).
• Aligned with procurement line items (licenses, maintenance, services).

Common B2G-friendly value metrics in medtech SaaS:

• Per site/facility (e.g., per VA medical center, per county clinic). Procurement likes this because it maps to organizational units.
• Per program (e.g., stroke program, sepsis surveillance program). Works when your product is tied to a specific initiative.
• Per device endpoint (if you manage connected devices). Clear inventory-based scaling.
• Per volume band (e.g., up to X studies/month, up to Y patients monitored). Avoids per-click nickel-and-diming while still scaling with load.

Metrics to be careful with:

• Per seat can be painful in government because staffing levels fluctuate, shared accounts are common, and “who counts as a user?” becomes a negotiation.
• Per patient can trigger privacy and reporting concerns and may be hard to reconcile with how agencies track populations.

Use a three-part price structure: subscription + implementation + compliance add-ons

A clean way to price B2G SaaS in medtech is to separate what you’re selling into three buckets. This reduces procurement friction and protects your margins.

1) Base subscription (annual)

This is the recurring license for the software. Keep it simple: one unit (site/program/device band) and 2–3 tiers. Example tier logic (not numbers):

• Tier 1: Pilot / limited scope (single site, limited modules, limited integrations)
• Tier 2: Production (full module set, standard integrations, standard support)
• Tier 3: Enterprise / multi-site (multiple facilities, advanced analytics, higher uptime/support commitments)

Government buyers often prefer annual terms. Multi-year can work, but only if it aligns with their contracting vehicle and budget authority.

2) Implementation / onboarding (one-time or milestone-based)

Implementation is where medtech SaaS companies accidentally give away the business. Government environments often require:

• Security questionnaires and evidence packages
• Network approvals
• Identity/access setup (SSO, role-based access)
• EHR integration (HL7/FHIR), imaging (DICOM), device feeds
• Training, SOPs, and change management

Price implementation as a fixed fee with a defined scope or as milestones (e.g., “go-live at 1 site,” “integration completed,” “training delivered”). This is procurement-friendly because it looks like professional services rather than a mysterious “higher subscription.”

3) Compliance/security and premium support (optional add-ons)

Some agencies will require additional controls or documentation beyond your baseline. Instead of baking this into every deal, define add-ons such as:

• Enhanced security package (additional attestations, penetration testing coordination, custom reporting)
• Data retention/archival requirements
• 24/7 support or faster response SLAs (service-level agreements)

This keeps your base price competitive while giving you a legitimate way to charge for real incremental work.

Design pricing to survive procurement: pilots, contract vehicles, and “not-to-exceed”

B2G deals often start as pilots. The trap is offering a “cheap pilot” that becomes a permanent low-price deployment. Instead, structure pilots so they are:

• Time-boxed (e.g., 3–6 months, or “until evaluation complete”)
• Scope-boxed (one site, one workflow, limited integrations)
• Conversion-boxed (pre-defined path to production pricing)

Two procurement-friendly tactics:

• Not-to-exceed (NTE) pricing: You define a maximum spend for the pilot/phase, which helps agencies manage risk. You still need clear assumptions so you don’t eat unlimited scope.
• Option years: Price Year 1 (including implementation) differently from Years 2–3 (mostly subscription). This matches the reality that Year 1 costs more.

Also, be prepared for the government to ask for pricing artifacts like a rate card for services, a catalog of modules, or tier definitions. If you can present your pricing like a “menu,” you reduce negotiation time.

Anchor price to outcomes, but speak the language of budgets and reimbursement

In medtech, you may be tempted to price on clinical outcomes (reduced readmissions, faster diagnosis, fewer adverse events). That’s directionally right, but government buyers still need a budget justification that is auditable and not speculative.

Practical ways to connect value to price without overpromising:

• Operational ROI: time saved per clinician, reduced manual chart review, fewer duplicate tests. These are easier to defend than clinical outcome claims.
• Program compliance: improved reporting completeness, audit readiness, quality measure tracking.
• Capacity: ability to manage more patients/devices with the same staff.

If your product touches billing workflows, understand that government and hospital stakeholders may ask about CPT codes (billing codes used for reimbursement) and whether your solution enables reimbursable services. Don’t claim reimbursement certainty unless you have it; reimbursement varies by payer and setting. Still, being conversant in how reimbursement could work can strengthen your pricing narrative.

If you need clinical evidence (common in medtech), factor in whether you’ll run studies under IRB approval (Institutional Review Board oversight). Evidence generation can be part of a paid pilot (with clear deliverables) rather than an unfunded “trial.”

Common pricing mistakes in B2G medtech SaaS (and how to avoid them)

• Mistake: One price for everyone. Government environments vary wildly in security and integration burden. Fix: standardize tiers, but keep implementation scoped and priced separately.
• Mistake: Discounting pilots without a conversion plan. Fix: write the pilot SOW (statement of work) so it naturally rolls into production with pre-agreed pricing logic.
• Mistake: Per-seat pricing that punishes adoption. Fix: prefer per-site/program/device bands; if you must do seats, include generous seat bundles.
• Mistake: Ignoring regulatory posture. If FDA status is unclear, buyers perceive risk. Fix: be explicit about intended use, risk controls, and which pathway (510(k), De Novo, PMA) you believe applies (or that it’s under assessment).
• Mistake: Underestimating procurement time. Fix: price for longer sales cycles by ensuring your ACV (annual contract value) can support the effort, or focus on smaller agencies/contract vehicles first.

What to do next

1. Define your value metric (site/program/device/volume band) and write a one-page pricing sheet with 2–3 tiers plus a separate implementation fee.
2. Build a pilot package that is time-boxed and scope-boxed, with a written conversion path to production pricing (option years or tier upgrade).
3. Create a services rate card for integrations, training, and security documentation so procurement can buy “extra work” cleanly.
4. Map your compliance posture (security requirements, IRB needs, and FDA pathway assumptions) and decide what’s included vs. an add-on.
5. Pressure-test pricing with 5 buyer interviews (procurement + clinical champion + IT/security) and revise the tier definitions before you scale outreach.